15 completed. 15 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 15 |
| Phase 2 | 2 | Completed 2 |
Follow Cerebral Infarction: new trials by email Literature Review of Cerebral Infarction trials Research Report on Cerebral Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion Tenecteplase, direct EVT - Ischemic Stroke, Acute, Thrombolysis | Phase 3 | Completed | Beijing Tiantan Hospital | 391 | 2024-01-25 | 2025-11-26 |
| Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke Normal Saline along with standard treatment, PMZ-1620 (sovateltide) along with standard treatment - Cerebral Ischemia, Cerebral Infarction | Phase 3 | Completed | Pharmazz, Inc. | 158 | 2019-11-10 | 2023-10-18 |
| DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval Direct endovascular clot retrieval, Bridging thrombolysis followed by ECR - Ischemic Stroke | Phase 3 | Completed | Neuroscience Trials Australia | 295 | 2018-04-27 | 2022-06-16 |
| The Carotid and Middle Cerebral Artery Occlusion Surgery Study bypass surgery, Aspirin, Clopidogrel - Carotid Artery Occlusion, Middle Cerebral Artery Occlusion | Phase 3 | Completed | Xuanwu Hospital, Beijing | 330 | 2013-06-06 | 2021-11-12 |
| Action of Amantadine on Post-Stroke Aphasic Patients Amantadin, Placebo - Cerebral Infarction | Phase 2 / Phase 3 | Completed | Centre Hospitalier Universitaire de Nice | 50 | 2009-03-01 | 2014-04-21 |
| Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia Melodic Intonation Therapy, Speech-Repetition-Therapy - Aphasia, Stroke | Phase 3 | Completed | Beth Israel Deaconess Medical Center | 30 | 2008-02-01 | 2020-09-21 |
| CHInese Medicine NeuroAid Efficacy on Stroke Recovery NeuroAid, NeuroAid matched Placebo - Cerebral Infarction, Stroke | Phase 3 | Completed | CHIMES Society | 1100 | 2007-05-01 | 2014-05-01 |
| Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke Cilostazol 200mg/day Oral, Aspirin 100mg/day Oral - Cerebral Infarction | Phase 3 | Completed | Otsuka Beijing Research Institute | 720 | 2004-05-01 | 2006-03-16 |
| Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Pharmacology Study MCI-9042 - Cerebral Infarction | Phase 3 | Completed | Tanabe Pharma Corporation | 46 | 2004-04-01 | 2015-04-10 |
| ExStroke Pilot Trial: Physical Exercise After Acute Ischaemic Stroke Instruction in physical training program - Stroke | Phase 3 | Completed | Bispebjerg Hospital | 314 | 2003-09-01 | 2007-10-22 |
| Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke recombinant human erythropoietin alfa, 0.9% NaCl - Infarction, Middle Cerebral Artery, Middle Cerebral Artery Stroke | Phase 2 / Phase 3 | Completed | Max-Planck-Institute of Experimental Medicine | 522 | 2003-01-01 | 2008-10-22 |
| Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke Alteplase - Cerebral Infarction, Brain Ischemia | Phase 3 | Completed | Tanabe Pharma Corporation | 103 | 2002-04-01 | 2026-01-05 |
| Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) MCI-9042, Aspirin - Cerebral Infarction | Phase 3 | Completed | Tanabe Pharma Corporation | 1510 | 2001-01-01 | 2008-08-19 |
| Vitamin Therapy for Prevention of Stroke pyridoxine, cyanocobalamin, folic acid multivitamin - Stroke, Cerebral Infarction | Phase 3 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 1996-09-01 | 2005-06-24 | |
| Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction. cilostazol, placebo of cilostazol - Cerebral Infarction | Phase 3 | Completed | Otsuka Pharmaceutical Co., Ltd. | 1095 | 1992-04-01 | 2021-03-01 |
Stroke (10) · Brain Ischemia (4) · Infarction, Middle Cerebral Artery (3) · Brain Infarction (2) · Cerebrovascular Disorders (2) · Ischemia (2) · Ischemic Stroke (2) · Aphasia (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Hypoxia (1) · Motor Activity (1) · Myocardial Infarction (1)
Infarction (15) · Necrosis (15) · Pathological Conditions, Signs and Symptoms (15) · Brain Diseases (14) · Cardiovascular Diseases (14) · Central Nervous System Diseases (14) · Nervous System Diseases (14) · Pathologic Processes (14) · Vascular Diseases (14) · Brain Infarction (13) · Cerebrovascular Disorders (13) · Ischemia (13) · Brain Ischemia (11) · Stroke (5) · Cerebral Arterial Diseases (3)
Aspirin (3) · Cilostazol (2) · sarpogrelate (2) · Amantadine (1) · Clopidogrel (1) · Coronary Artery Bypass (1) · Educational Status (1) · Neuroaid (1) · Pyridoxine (1) · Saline Solution (1) · Tenecteplase (1) · Tissue Plasminogen Activator (1) · Vitamin B 12 (1) · sovateltide (1)
Tanabe Pharma Corporation (3) · Beijing Tiantan Hospital (1) · Beth Israel Deaconess Medical Center (1) · Bispebjerg Hospital (1) · CHIMES Society (1) · Centre Hospitalier Universitaire de Nice (1) · Max-Planck-Institute of Experimental Medicine (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Neuroscience Trials Australia (1) · Otsuka Beijing Research Institute (1) · Otsuka Pharmaceutical Co., Ltd. (1) · Pharmazz, Inc. (1) · Xuanwu Hospital, Beijing (1)
China (4) · Japan (2) · Singapore (2) · United States (2) · Australia (1) · Denmark (1) · France (1) · Germany (1) · Hong Kong (1) · India (1) · Malaysia (1) · Philippines (1) · Sri Lanka (1) · Thailand (1) · Vietnam (1)
Andrea Norton, BM (1) · Anil Gulati, MD, PhD (1) · Bernard Yan, MD (1) · Christopher Chen, MBBS (1) · Feng Ling, MD (1) · Fengyuan Che, MD (1) · Gottfried Schlaug, MD, PhD (1) · Gudrun Boysen, MD (1) · James F. Toole, M.D. (1) · Marie Germaine Bousser, MD (1) · Peter Mitchell, MD (1) · Shinichiro Uchiyama, MD (1)
PMID 16763187, PMID 17494672, PMID 17622759, PMID 18029233, PMID 18388340, PMID 18456558, PMID 19673813, PMID 19834012, PMID 19900934, PMID 21197418, PMID 21737309, PMID 21852153, PMID 21960571, PMID 22068990, PMID 22668888, PMID 22949472, PMID 23780952, PMID 24135924, PMID 26628386, PMID 27852286, PMID 33428177, PMID 35135060, PMID 35810757, PMID 37606672, PMID 38934799, PMID 39334395, PMID 39542995, PMID 39727027, PMID 40534574, PMID 42099212, PMID 9757852
R01DC008796 (1)